NBC News: Patients weren't asked why they quit taking the weight loss drugs

Reuters

Reuters

Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.

PUBLICATIONS FDA Decisions Expected: July 2025 Your monthly synopsis of new drugs expected to hit the market June 18, 2025 Drug pipeline for July 2025 At Prime Therapeutics (Prime), we have...

publications High-Cost Therapy Profile: November 2025 Tividenofusp alfa Intravenous (IV) | Denali Therapeutics Metabolic November 14, 2025 Proposed indications Mucopolysaccharidosis type II (MPS...

publications High-Cost Therapy Profile: June 2025 Zopapogene imadenovec Subcutaneous (SC) | Precigen, Inc. Infectious Disease June 18, 2025 Proposed indications Recurrent respiratory...

Marquee event showcased new Prime, our energy, ambition and transformative journey

Drug Approvals Quarterly Update: April 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

AMCP Nexus 2025 research posters Studies on GLP-1 drugs, specialty therapies and more help improve affordability in health care Click on the poster image to view the full-size version. Prime...

research 8 research posters presented by Prime at the 2024 AMCP Annual Meeting Prime remains at the forefront of researching real-world drug utilization, managed care pharmacy programs, and costs...

AMCP Annual Meeting 2025 research posters Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model Click on the poster image to view the full-size version. Prime...

Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...

publications Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches July 31, 2024 Specialty New drugs Jun. 20,...

publications Weight management: A holistic journey May 1, 2024 Obesity is a global epidemic and major public health issue that has grown in prevalence over recent decades in adults, adolescents...

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...

publications Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches February 28, 2025 Specialty New drugs...

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...